It has been shown that in lung cancer, higher expression of H19 is positively correlated with poor prognosis, and its knockdown significantly reduces tumor cell proliferation, suggesting that H19 plays a pivotal role in NSCLC progression [49,50]. This evidence concerns the gene H19 and lung carcinoma.